{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:05:27Z","timestamp":1792134327380,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the frequency and types of incidental findings on prostate MRI in a screening setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Prostate MRI reports from 2020 to 2024 for men aged 50\u201356 years were collected from three regional organised prostate cancer testing (OPT) programmes in Sweden. Incidental findings were categorised as suspicious for extra-prostatic malignancy, otherwise likely clinically relevant or of low or no clinical relevance that do not motivate contact with the screened man. Confidence intervals (CI) were calculated for proportions of scans with an incidental finding. Chi-square testing was used to test inter-regional differences of reported findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At least one incidental finding was described in 119\/1202 (9.9%) MRI reports. Ten reports described two incidental findings. Most (112\/129, 87%) were categorised as of low or no clinical relevance, with inguinal hernia and colon diverticulosis being the most common. Proportions of these findings varied significantly (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005) between the regions: 47\/355 (13%; 95% CI 10\u201317%), 47\/539 (8.7%; 95% CI 6.5\u201311%) and 15\/308 (5.8%; 95% CI 3.5\u20139.0%). Overall, 17\/1202 (1.4%) of the reports described a suspected extra-prostatic malignancy or otherwise clearly clinically relevant incidental finding. Suspected extra-prostatic malignancy findings were four suspected tumours in the rectum, four suspected tumours in the bladder and two bone metastases with an unknown primary tumour.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Screening prostate MRI in men in their fifties yields few incidental findings of clear clinical importance. Reporting of incidental findings of low\/no clinical relevance varies between centres. Consensus-based guidelines are needed to define which types of incidental findings should be reported and notified to the screened individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>Screening prostate MRI detects few incidental findings of clear clinical relevance. Findings of low or no clinical relevance are variably reported, which calls for consensus-based guidelines on which types of incidental findings on screening prostate MRI should be reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>No previous study has reported incidental findings on prostate MRI in a population-based screening setting.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Screening prostate MRI detects few incidental findings of clear clinical relevance.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Incidental findings of low or no clinical relevance are variably reported across centres.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>There is a need for consensus-based guidelines for which types of incidental findings on screening prostate MRI should be reported and notified to the screened individual.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-025-02147-7","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T09:36:09Z","timestamp":1763976969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidental findings on prostate MRI in a population-based screening setting"],"prefix":"10.1186","volume":"16","author":[{"given":"Victoria","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Thimansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jiborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"J\u00e4derling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecka Arnsrud","family":"Godtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4453-6718","authenticated-orcid":false,"given":"Jonas","family":"Wallstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Bratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2147_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/JU.0000000000002696","volume":"208","author":"M Fr\u00e5nlund","year":"2022","unstructured":"Fr\u00e5nlund M, M\u00e5nsson M, Godtman RA et al (2022) Results from 22 years of followup in the Goteborg randomized population-based prostate cancer screening trial. J Urol 208:292\u2013300","journal-title":"J Urol"},{"key":"2147_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","volume":"76","author":"J Hugosson","year":"2019","unstructured":"Hugosson J, Roobol MJ, M\u00e5nsson M et al (2019) A 16-yr follow-up of the European randomized study of screening for prostate cancer. Eur Urol 76:43\u201351","journal-title":"Eur Urol"},{"key":"2147_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1001\/jama.2024.3841","volume":"331","author":"A Auvinen","year":"2024","unstructured":"Auvinen A, Tammela TLJ, Mirtti T et al (2024) Prostate cancer screening with PSA, kallikrein panel, and MRI: the ProScreen randomized trial. JAMA 331:1452\u20131459","journal-title":"JAMA"},{"key":"2147_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa2406050","volume":"391","author":"J Hugosson","year":"2024","unstructured":"Hugosson J, Godtman RA, Wallstr\u00f6m J et al (2024) Results after four years of screening for prostate cancer with PSA and MRI. N Engl J Med 391:1083\u20131095","journal-title":"N Engl J Med"},{"key":"2147_CR5","unstructured":"European Union Council (2022) Council recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening replacing Council Recommendation 2003\/878\/EC 2022\/C 473\/1. Off J Eur Union 473:1\u201310"},{"key":"2147_CR6","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.euf.2022.06.008","volume":"8","author":"M Alterbeck","year":"2022","unstructured":"Alterbeck M, J\u00e4rbur E, Thimansson E et al (2022) Designing and implementing a population-based organised prostate cancer testing programme. Eur Urol Focus 8:1568\u20131574","journal-title":"Eur Urol Focus"},{"key":"2147_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2340\/sju.v60.43809","volume":"60","author":"O Bratt","year":"2025","unstructured":"Bratt O, Butt ST, Carlsson C et al (2025) Swedish regional population-based organised prostate cancer testing: why, what and how? Scand J Urol 60:97\u2013104","journal-title":"Scand J Urol"},{"key":"2147_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11547-019-01106-9","volume":"125","author":"G Cutaia","year":"2020","unstructured":"Cutaia G, Tosto G, Cannella R et al (2020) Prevalence and clinical significance of incidental findings on multiparametric prostate MRI. Radiol Med 125:204\u2013213","journal-title":"Radiol Med"},{"key":"2147_CR9","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.29271\/jcpsp.2021.09.1030","volume":"31","author":"SS Ediz","year":"2021","unstructured":"Ediz SS, Gunduz N (2021) The relationship between PI-RADS categories and incidental findings in multiparametric prostate MRI. J Coll Physicians Surg Pak 31:1030\u20131034","journal-title":"J Coll Physicians Surg Pak"},{"key":"2147_CR10","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.5114\/pjr.2022.118312","volume":"87","author":"E Emekli","year":"2022","unstructured":"Emekli E, Gundogdu E (2022) Evaluation of the frequency of incidental findings and their clinical significance in multiparametric prostate magnetic resonance imaging examination. Pol J Radiol 87:e409\u2013e414","journal-title":"Pol J Radiol"},{"key":"2147_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.110984","volume":"166","author":"A Ponsiglione","year":"2023","unstructured":"Ponsiglione A, Campo I, Sachs C et al (2023) Extraprostatic incidental findings on prostate mpMRI: a pictorial review from the ESUR junior network. Eur J Radiol 166:110984","journal-title":"Eur J Radiol"},{"key":"2147_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00261-017-1237-x","volume":"43","author":"RL Sherrer","year":"2018","unstructured":"Sherrer RL, Lai WS, Thomas JV, Nix JW, Rais-Bahrami S (2018) Incidental findings on multiparametric MRI performed for evaluation of prostate cancer. Abdom Radiol (NY) 43:696\u2013701","journal-title":"Abdom Radiol (NY)"},{"key":"2147_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-025-00846-4","volume":"25","author":"F Poroes","year":"2025","unstructured":"Poroes F, Karampa P, Sartoretti T et al (2025) Additional findings in prostate MRI. Cancer Imaging 25:29","journal-title":"Cancer Imaging"},{"key":"2147_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/bju.16582","volume":"135","author":"E Thimansson","year":"2025","unstructured":"Thimansson E, Ax\u00e9n E, J\u00e4derling F et al (2025) A novel approach to integrated prostate cancer diagnostics: insights from MRI, prostate biopsy, and pathology reports in a pilot study. BJU Int 135:245\u2013248","journal-title":"BJU Int"},{"key":"2147_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76:340\u2013351","journal-title":"Eur Urol"},{"key":"2147_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2214\/AJR.22.28926","volume":"221","author":"MS Davenport","year":"2023","unstructured":"Davenport MS (2023) Incidental findings and low-value care. AJR Am J Roentgenol 221:117\u2013123","journal-title":"AJR Am J Roentgenol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02147-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-02147-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02147-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:02:50Z","timestamp":1764021770000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-025-02147-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2147"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-02147-7","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data collection and the study were approved by the Swedish Ethical Review Authority (2024-01684-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication by \u201copt in\u201d was approved by the Swedish Ethical Review Authority (2020-03923).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}